Emergent Biosolutions Inc. EV/EBITDA

EV/EBITDA of EBS for past 10 years: annual, quarterly and twelve month trailing (TTM) including EV/EBITDA growth rates and interactive chart. EV/EBITDA is a ratio that compares a company’s Enterprise Value (EV) to its Earnings Before Interest, Taxes, Depreciation & Amortization (EBITDA). The EV/EBITDA ratio is a valuation metric used to compare the relative value of different businesses. A low EV/EBITDA compared to a stock’s historical average or industry can indicate undervaluation.

Highlights and Quick Summary

Current EV/EBITDA of Emergent Biosolutions Inc. is 0.0 (as of December 31, 2022)
  • EV/EBITDA for the quarter ending June 30, 2023 was 0.0 (a NaN% decrease compared to previous quarter)
  • Year-over-year quarterly EV/EBITDA decreased by -100.0%
  • Annual EV/EBITDA for 2022 was 0.0 (a -100.0% decrease from previous year)
  • Annual EV/EBITDA for 2021 was 5.39 (a -40.27% decrease from previous year)
  • Annual EV/EBITDA for 2020 was 9.03 (a -39.91% decrease from previous year)
Visit stockrow.com/EBS for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical EV/EBITDA of Emergent Biosolutions Inc.

Most recent EV/EBITDAof EBS including historical data for past 10 years.

Interactive Chart of EV/EBITDA of Emergent Biosolutions Inc.

Emergent Biosolutions Inc. EV/EBITDA for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2023 0.0 0.0 – – –
2022 0.0 6.0 6.34 6.3 0.0
2021 5.39 6.8 6.84 7.98 5.39
2020 9.03 16.06 12.38 14.76 9.03
2019 15.02 21.31 32.61 21.17 15.02
2018 23.89 16.04 11.7 16.15 23.89
2017 10.92 9.95 8.82 8.38 10.92
2016 9.15 6.92 5.15 5.94 9.15
2015 8.4 6.34 9.74 9.37 8.4
2014 8.14 12.2 18.66 19.62 8.14
2013 11.65 9.53 8.84 9.95 11.65
2012 12.14 – – – 12.14

Business Profile of Emergent Biosolutions Inc.

Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic
© stockrow.com